Atorvastatin as a potential antimalarial drug: In vitro synergy in combinational therapy with dihydroartemisinin

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 966-967

  Savini, Hélène ^a   Souraud, Jean Baptiste ^a   Briolant, Sébastien ^b   Baret, Eric ^b   Amalvict, Rémy ^b   Rogier, Christophe ^b   Pradines, Bruno ^b  

^a LAVERAN MILITARY TEACHING HOSPITAL   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIMALARIAL AGENT; ATORVASTATIN; CARRIER PROTEIN; DIHYDROARTEMISININ; QUINOLINE;

ANALYSIS OF VARIANCE; BROTH DILUTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; LETTER; MAXIMUM PLASMA CONCENTRATION; METHODOLOGY; PARASITE CULTIVATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 75749105081     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01006-09     Document Type: Letter

References (13)

1. Bienvenu, A. L., and S. Picot. 2008. Statins alone are ineffective in cerebral malaria but potentiate artesunate. Antimicrob. Agents Chemother. 52:4203-4204.
2. Borek-Dohalsky, V., J. Huclova, B. Barrett, B. Nemec, I. Ulc, and I. Jelinek. 2006. Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroatorvastatin in human plasma-pharmacokinetic study. Anal. Bioanal. Chem. 386:275-285.
3. Carrara, V. I., J. Zwang, E. A. Ashley, R. N. Price, K. Stepniewska, M. Barends, A. Brockman, T. Anderson, R. McGready, L. Phaiphun, S. Proux, M. van Vugt, R. Hutagalung, K. M. Lwin, A. P. Phyo, P. Preechapornkul, M. Imwong, S. Pukrittayakamee, P. Singhasivanon, N. J. White, and F. Nosten. 2009. Changes in the treatment responses to artesunate-mefloquine on the Northwestern border of Thailand during 13 years of continuous deployment. PlosOne 4:e4451.
4. Clark, I. A., L. M. Alleva, A. C. Mills, and W. B. Cowden. 2004. Pathogenesis of malaria and clinically similar conditions. Clin. Microbiol. Rev. 17:509-539.
5. Henry, M., S. Alibert, M. Baragatti, J. Mosnier, E. Baret, R. Amalvict, E. Legrand, T. Fusai, J. Barbe, C. Rogier, J. M. Pagès, and B. Pradines. 2008. Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria. Med. Chem. 4:426-437.
6. + exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob. Agents Chemother. 53:1926-1930.
7. Kruger, P. S., N. M. Freir, B. Venkatesh, T. A. Robertson, M. S. Roberts, and M. Jones. 2009. A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med. 35:717-721.
8. Parquet, V., S. Briolant, M. Torrentino-Madamet, M. Henry, L. Almeras, R. Amalvict, E. Baret, T. Fusai, C. Rogier, and B. Pradines. 2009. Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob. Agents Chemother. 53:2248-2252.
9. Posvar, E. L., L. L. Radulovic, D. D. Cilla, L. R. Whitfield, and A. J. Sedman. 1996. Tolerance and Pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects. J. Clin. Pharmacol. 36:728-731.
10. Pradines, B., M. Torrentino-Madamet, A. Fontaine, M. Henry, E. Baret, J. Mosnier, S. Briolant, T. Fusai, and C. Rogier. 2007. Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob. Agents Chemother. 51:2654-2655.
11. Rogers, W. O., R. Sem, T. Tero, P. Chim, P. Lim, S. Muth, D. Socheat, F. Ariey, and C. Wongsrichanalai. 2009. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J. 8:10.
12. Shah, N. K., A. P. Akler, R. Sem, A. I. Susanti, S. Muth, J. D. Maguire, S. Duong, F. Ariey, S. R. Meshnick, and C. Wongsrichanalai. 2008. Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia. Emerg. Infect. Dis. 14:1637-1640.
13. Wong, R. P. M., and T. M. E. Davis. 2009. Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs. Antimicrob. Agents Chemother. 53:2212-2214.